Tevogen TVGN
NASDAQ TVGN
$7.29 -0.05 (-0.68%)
At close: Sep 10, 2026 · 4:00 PM EDT

Tevogen (TVGN) Retained Earnings (2021 - 2026)

Tevogen's (TVGN) quarterly Retained Earnings came in at -$145.1 million in Q1 2026, down 17.26% on a YoY basis from -$175.4 million in Q1 2025, and down 3.9% quarter-over-quarter from -$139.7 million in Q4 2025.

Analysis

Tevogen (TVGN) Retained Earnings (2021 - 2026) Analysis & Trends

Tevogen (TVGN) has reported Retained Earnings for 6 consecutive years, with -$145.1 million the latest figure, recorded in Q1 2026.

  • For the quarter ending Q1 2026, Retained Earnings fell 17.26% year-over-year to -$145.1 million; the trailing twelve-month figure through Mar 2026 stood at -$145.1 million (down 17.26% YoY), and the FY2025 full-year result was -$139.7 million, down 23.17% from the prior year.
  • Retained Earnings declined to -$145.1 million in Q1 2026 per TVGN's latest filing, from -$139.7 million in the prior quarter.
  • Across five years, Retained Earnings topped out at -$14.0 million in Q2 2022 and bottomed at -$145.1 million in Q1 2026.
  • Historically, Retained Earnings has averaged -$75.4 million across 5 years, with a median of -$98.1 million in 2024.
  • The sharpest annual moves came in 2022 and 2023: Retained Earnings fell 3.9% in 2022, then sank 574.06% in 2023.
  • Over 5 years, Retained Earnings stood at -$14.8 million in 2022, then tumbled by 574.06% to -$99.7 million in 2023, then declined by 13.77% to -$113.4 million in 2024, then retreated by 23.17% to -$139.7 million in 2025, then fell by 3.9% to -$145.1 million in 2026.
  • According to Business Quant data, Retained Earnings over the past three periods registered -$145.1 million, -$139.7 million, and -$135.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Krystal Biotech 10.21 Bn 9.37 Bn 112.79 Mn 1.23 Bn
2 CRISPR Therapeutics AG 5.04 Bn 5.04 Bn - -2.16 Bn
3 Iovance Biotherapeutics 3.65 Bn 3.36 Bn 55.72 Mn 3.62 Bn
4 Legend Biotech 3.54 Bn 2.57 Bn 251.50 Mn 1.23 Bn
5 uniQure 2.95 Bn 2.95 Bn 5.49 Mn 1.84 Bn
6 Beam Therapeutics 2.55 Bn 2.55 Bn - 2.93 Bn
7 Precigen 2.39 Bn 2.39 Bn 52.17 Mn 2.37 Bn
8 Sarepta Therapeutics 2.16 Bn 1.37 Bn 251.87 Mn -4.55 Bn
9 Vericel 1.93 Bn 1.77 Bn 56.40 Mn -380.40 Mn
10 Tevogen 27.76 Mn 27.76 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -145.11 Mn
Dec 31, 2025 -139.66 Mn
Sep 30, 2025 -134.98 Mn
Jun 30, 2025 -129.26 Mn
Mar 31, 2025 -123.75 Mn
Dec 31, 2024 -113.39 Mn
Sep 30, 2024 -103.94 Mn
Jun 30, 2024 -98.06 Mn
Mar 31, 2024 -88.39 Mn
Dec 31, 2023 -99.66 Mn
Sep 30, 2023 -16.16 Mn
Jun 30, 2023 -15.55 Mn
Mar 31, 2023 -15.33 Mn
Dec 31, 2022 -14.78 Mn
Sep 30, 2022 -14.66 Mn
Jun 30, 2022 -14.05 Mn
Mar 31, 2022 -14.26 Mn
Dec 31, 2021 -14.23 Mn